A Study on the Prospective Cohort Library of COVID-19 in Southeran

NCT ID: NCT04342702

Last Updated: 2020-05-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

504 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-03-16

Study Completion Date

2021-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multi-centre population-based follow-up study for all 504 patients with laboratory-confirmed COVID-19. This study establishes a standardized and structured clinical database to provide complete and multidimensional clinical diagnosis and treatment data of novel coronavirus pneumonia, which also support future epidemiological, infectious disease study and patients' prognosis, by collecting clinical data and the related data of patients with novel coronavirus pneumonia in Southern Zhejiang province.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The follow-up information will be collected in one-month, three-month, six-month and one-year after discharge. Information about symptoms, radiographic and laboratory findings, lung function, SF-36 QUESTIONNAIRE, antibody of COVID19,result of RT-PCR Test and suvival information will be collected through all time frames.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Follow-up COVID-19 Infectious Diseases Respiratory

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients with laboratory-confirmed COVID-19 in Wenzhou

Exclusion Criteria

* Suspected cases of COVID-19
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wenzhou Medical University

OTHER

Sponsor Role collaborator

First Affiliated Hospital of Wenzhou Medical University

OTHER

Sponsor Role collaborator

Wenzhou Central Hospital And Sixth People's Hospital of Wenzhou Medical University

UNKNOWN

Sponsor Role collaborator

Yueqing Hospital of Wenzhou Medical University

UNKNOWN

Sponsor Role collaborator

Ruian Hospital of Wenzhou Medical University

UNKNOWN

Sponsor Role collaborator

Cangnan Hospital of Wenzhou Medical University

UNKNOWN

Sponsor Role collaborator

Pingyang Hospital of Wenzhou Medical University

UNKNOWN

Sponsor Role collaborator

Yongjia People's Hospital

UNKNOWN

Sponsor Role collaborator

Second Affiliated Hospital of Wenzhou Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Xiaokun Li

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Wenzhou Medical University

Wenzhou, Zhejiang, China

Site Status

The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SAHoWMU-CR2020-NCP-202

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Survey of COVID-19 Infection
NCT05706064 COMPLETED